<SEC-DOCUMENT>0001640334-20-000917-index.html : 20200424
<SEC-HEADER>0001640334-20-000917.hdr.sgml : 20200424
<ACCEPTANCE-DATETIME>20200424171500
ACCESSION NUMBER:		0001640334-20-000917
CONFORMED SUBMISSION TYPE:	F-3/A
PUBLIC DOCUMENT COUNT:		6
FILED AS OF DATE:		20200424
DATE AS OF CHANGE:		20200424

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NYMOX PHARMACEUTICAL CORP
		CENTRAL INDEX KEY:			0001018735
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		F-3/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-237564
		FILM NUMBER:		20816028

	BUSINESS ADDRESS:	
		STREET 1:		9900 CAVENDISH BLVD., SUITE 306
		STREET 2:		ST. LAURENT
		CITY:			QUEBEC CANADA
		STATE:			A8
		ZIP:			H4M 2V2
		BUSINESS PHONE:		1-800-936-9669

	MAIL ADDRESS:	
		STREET 1:		9900 CAVENDISH BLVD., SUITE 306
		STREET 2:		ST. LAURENT
		CITY:			QUEBEC CANADA
		STATE:			A8
		ZIP:			H4M 2V2
</SEC-HEADER>
<DOCUMENT>
<TYPE>F-3/A
<SEQUENCE>1
<FILENAME>nymx_f3a.htm
<DESCRIPTION>FORM F-3/A
<TEXT>
Document 1 - file: nymx_f3a.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>nymx_ex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
Document 2 - file: nymx_ex51.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10
<SEQUENCE>3
<FILENAME>nymx_ex10.htm
<DESCRIPTION>EX-10
<TEXT>
Document 3 - file: nymx_ex10.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>nymx_ex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
Document 4 - file: nymx_ex231.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>nymx_f3aimg1.jpg
<TEXT>
Document 5 - file: nymx_f3aimg1.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>nymx_ex231img1.jpg
<TEXT>
Document 6 - file: nymx_ex231img1.jpg

</DOCUMENT>
</SEC-DOCUMENT>